GRP
BMRN icon

Global Retirement Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History

Global Retirement Partners’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$281K Buy
+4,906
New +$269K ﹤0.01% 1373
2025
Q4 		$219K Buy
3,691
+2,440
+195% +$133K ﹤0.01% 1411
2025
Q3 		$67.8K Sell
1,251
-1,274
-50% -$72.9K ﹤0.01% 1729
2025
Q2 		$139K Buy
+2,525
New +$149K ﹤0.01% 1271
2024
Q4 		$178K Buy
2,708
+422
+18% +$28.3K 0.01% 1013
2024
Q3 		$161K Buy
2,286
+4
+0.2% +$334 ﹤0.01% 1007
2024
Q2 		$188K Buy
2,282
+10
+0.4% +$833 0.01% 910
2024
Q1 		$198K Buy
2,272
+40
+2% +$3.58K 0.01% 793
2023
Q4 		$209K Sell
2,232
-37
-2% -$3.27K 0.01% 748
2023
Q3 		$195K Buy
2,269
+14
+0.6% +$1.25K 0.01% 675
2023
Q2 		$195K Buy
2,255
+148
+7% +$13.9K 0.01% 707
2023
Q1 		$197K Buy
2,107
+7
+0.3% +$726 0.01% 672
2022
Q4 		$217K Sell
2,100
-50
-2% -$4.69K 0.01% 572
2022
Q3 		$186K Hold
2,150
– – 0.01% 581
2022
Q2 		$178K Buy
2,150
+50
+2% +$3.98K 0.01% 579
2022
Q1 		$165K Buy
+2,100
New +$176K 0.01% 601
2021
Q4 		– Sell
-2,020
Closed -$156K – 413
2021
Q3 		$156K Hold
2,020
– – 0.02% 529
2021
Q2 		$169K Sell
2,020
-10
-0.5% -$793 0.02% 499
2021
Q1 		$153K Buy
2,030
+7
+0.3% +$572 0.02% 465
2020
Q4 		$177K Buy
2,023
+100
+5% +$7.93K 0.02% 420
2020
Q3 		$146K Sell
1,923
-100
-5% -$10.1K 0.02% 412
2020
Q2 		$250K Buy
2,023
+16
+0.8% +$1.59K 0.04% 316
2020
Q1 		$170K Buy
2,007
+7
+0.4% +$603 0.03% 345
2019
Q4 		$169K Hold
2,000
– – 0.03% 396
2019
Q3 		$135K Hold
2,000
– – 0.02% 428
2019
Q2 		$171K Buy
2,000
+1,900
+1,900% +$163K 0.03% 363
2019
Q1 		$9K Buy
+100
New +$9.27K ﹤0.01% 1071

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Global Retirement Partners's BMRN Position: Q2 2026 in Review

Global Retirement Partners opened a new position in BioMarin Pharmaceuticals (BMRN) in Q2 2026: 4,906 shares worth $281K. The stake represents ﹤0.01% of the portfolio and ranks #1373 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in BMRN as recently as Q4 2025.

Global Retirement Partners first reported a position in BMRN in Q1 2019 and has held it in 27 quarters since. 565 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Global Retirement Partners held 4,906 shares of BioMarin Pharmaceuticals worth $281K as of Q2 2026.
  • BioMarin Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • BioMarin Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1373 holding.
  • Global Retirement Partners first reported a position in BioMarin Pharmaceuticals in Q1 2019 and has held it in 27 quarters since.
  • 565 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.